{"id":"W4402031327","doi":"10.1016/j.jtct.2024.08.015","title":"CAST Regimen for GvHD Prophylaxis: A CIBMTR Propensity Score-Matched Analysis","year":2024,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; NYU Grossman School of Medicine; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Seagen; BeiGene; Astellas Pharma; Adaptive Biotechnologies; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; Amgen; Rush University; HistoGenetics; U.S. Public Health Service; U.S. Department of Defense; Sanofi; GlaxoSmithKline; National Institute on Aging; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; U.S. Navy; Gateway for Cancer Research; Actinium Pharmaceuticals; CareDx; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences","keywords":"Propensity score matching; Regimen; Medicine; Internal medicine; Oncology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005428642,0.0001589219,0.0002907784,0.0001940775,0.0004408329,0.00002917166,0.00007175989,0.0001882744,0.0002614715],"category_scores_gemma":[0.000004419286,0.0001218517,0.0001232195,0.0004847358,0.00003093994,0.0001011962,0.000004475622,0.000304579,0.00004355194],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003673508,"about_ca_system_score_gemma":0.0001910693,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001921913,"about_ca_topic_score_gemma":0.0001541533,"domain_scores_codex":[0.9985517,0.0002617066,0.00035953,0.0003404055,0.0001657577,0.0003209071],"domain_scores_gemma":[0.9993789,0.0001714882,0.00006914942,0.0001526132,0.0000953023,0.0001325777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005379571,0.000362145,0.5464061,0.02316085,0.00255045,0.0003676937,0.1658413,0.00004328301,0.01316679,0.008772658,0.003817131,0.230132],"study_design_scores_gemma":[0.02743975,0.003848172,0.6778856,0.00207507,0.006965248,0.0000465098,0.01560617,0.01246152,0.0118236,0.00622118,0.2313145,0.004312641],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9528368,0.004683992,0.0374146,0.001383167,0.0004330381,0.002204441,0.0001481182,0.0002078875,0.0006880045],"genre_scores_gemma":[0.9927841,0.004016791,0.0002000135,0.0004868496,0.0003177729,0.0001605425,0.0004060585,0.00002717614,0.001600666],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2274974,"threshold_uncertainty_score":0.4968966,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1162576232521546,"score_gpt":0.3826355467407397,"score_spread":0.266377923488585,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}